- Town of Gold Bar, Wash. (pop. 2,100) brought to brink of bankruptcy by multiple lawsuits following political feuds; “We are going broke winning lawsuits,” says mayor [Monroe Monitor via ABA Journal]
- “No one in Youngstown Ohio has a Swiss bank account…except maybe that big new Swiss employer in town?” [Matt Welch, earlier] William McGurn: FATCA and the IRS’s reach abroad [WSJ via TaxProf, earlier here, here] Politicians and lawyers demand “improvements” to IRS bounty-paid-informant program, but what if anything they improve may depend on your point of view [TaxProf, earlier]
- A human rights professor endorses a new model of residential facility that comes with names like “Freedom Place.” But what’s that on the door — could it be a lock to prevent escape? [Maggie McNeill] Romney spokesman says he’ll smite smut, Gov. Gary Johnson takes a more libertarian view [Daily Caller]
- New Mark Herrmann book on in-house lawyering [Victoria Pynchon, Scott Greenfield, Paul Karlsgodt]
- Mortgage eminent-domain seizure plan raises serious constitutional concerns [Andrew Grossman, earlier here, here]
- Central casting? Send over one “business basher,” please: Sidney Wolfe says $3 billion Glaxo settlement too lenient [CL&P, earlier]
- Ted Frank pre-vets the possibilities for Romney VP [PoL] Romney’s law and legal policy team [Brian Baxter, AmLaw Daily]
Posts Tagged ‘pharmaceuticals’
“Warning labels can act as nocebos”
Perhaps there should be a warning label on pharmaceutical warning labels, since they can induce many of the side-effect symptoms they warn against [Maggie Koerth-Baker, BoingBoing]
Medical roundup
- How’d we get shortages of hospital and community sterile injectables? Check out the role of FDA Good Manufacturing Practice (GMP) regs, warning letters, and resulting plant closures [Tabarrok, with comments controversy; earlier here, here, here, etc.]
- California orthopedist sues, wins damages against medical society that took action against him based on his testimony for plaintiff in liability case [American Medical News; earlier here, etc.]
- Can’t have that: medical apology should be opposed because it “can create an emotional connection with an injured patient that makes the patient less likely to ask for compensation.” [Gabriel Teninbaum (Suffolk Law), Boston Globe]
- Feds’ war on painkillers is bad news for legit patients and docs [Reuters, Mike Riggs/Reason]
- New federal pilot project in Buffalo will provide concierge-style home care to emergency-department frequent fliers. Spot the unintended consequence [White Coat]
- Dastardly drug companies? Deconstructing Glaxo SmithKline’s $3 billion settlement [Greg Conko, MPT] More: Beck, Drug and Device Law, on suits over “what are mostly medically valid and beneficial off-label uses”. Paging Ted Frank: “HIPAA’s Vioxx toll” thesis may depend on whether one accepts that the premised Vioxx toll has been established [Stewart Baker, Ted’s recent post]
- U.K.: “Lawyers seizing lion’s share of payouts in NHS negligence cases” [Telegraph]
- Silver linings in SCOTUS ObamaCare ruling? [Jonathan Adler and Nathaniel Stewart] “DNC Scientists Disprove Existence of Roberts’ Taxon” [Iowahawk humor] Did Ginsburg hint at the court’s direction on the HHS contraception mandate? [Ed Morrissey, Hot Air]
[cross-posted at Cato at Liberty]
What Wyeth v. Levine did
The media and legal academy largely applauded the Supreme Court’s 2009 ruling on preemption, but Michael Greve deems its outcome “irresponsible and not even minimally rational”:
Under the Federal Food Drug and Cosmetics Act (FDCA), drugs sold in the United States require an FDA-approved label—the elaborate, incomprehensible (to laymen) sheets you find inside every package. Every sentence is dictated by FDA requirements, down to the font and letter size. Violations of these requirements, and the sale of drugs without the label or a different label, are subject to very severe penalties. The statutory scheme operates to the explicit exclusion of any state regulatory (administrative) scheme. What Wyeth asks us to believe is that state juries may nonetheless hold drug manufacturers liable, for accidents caused by use in direct contravention of the federal label, on the grounds that the federally required label was inadequate. Meticulous compliance with federal requirements doesn’t preempt “failure to warn” liability under state common law.
“School Nurse Denies Inhaler, Watches Student Lose Consciousness”
Following the rules in Florida: a 17-year-old high school student “very nearly died because the school nurse refused to let him use his inhaler because his mother didn’t sign a form.” [Isa-Lee Wolf, Yahoo via Free-Range Kids]
Medical roundup
- Government’s hospital care guidelines may be fueling dangerous overuse of antibiotics [White Coat] FDA says fewer drugs are in shortage [Reuters, earlier here, etc.]
- “Post-tort-reform Texas doctor supply” [Ted Frank/PoL and commenters] “Change in Procedures Lets Medical Malpractice [Insurance] Industry Thrive” [PC 360]
- Forcing companies to make politicized disclosures to customers implicates First Amendment [Hans Bader on HHS “must credit ObamaCare” reg]
- Iqbal and Twombly SCOTUS decisions on pleading have helped protect pharmaceutical defendants from flimsily based suits [James Beck, who has changed law firms to Reed Smith]
- How accurate is hospital data coding? Ask thousands of pregnant British men [Nigel Hawkes via Flowing Data]
- Class-action-fed boom in Medicaid dentistry + “let’s put docs in schools” idea = scope for horrific abuse, no matter how it’s financed [Bloomberg via Jesse Walker]
- Suits blaming obstetricians for cerebral palsy rack up $78 million win in Philadelphia, $74 million in California [Legal Intelligencer, Cal Coast News]
- Ninth Circuit: on reflection, let’s not seize control of VA mental health programs [AP, earlier here, etc.]
“Your seven-day pill box is illegal”
Ted Frank and Heather L. Finley of the Times-Georgian of west Georgia explain why.
Shortages of vital drugs hit Canada
And, surprisingly or not, there’s a U.S. Food and Drug Administration angle. [Marni Soupcoff, National Post/FP] Earlier here, here, etc.
March 15 roundup
- Part III of Radley Balko series on painkiller access [HuffPo]
- “Note: Add ‘Judge’s Nameplate’ to List of Things Not to Steal” [Lowering the Bar]
- California’s business-hostile climate: if the ADA mills don’t get you, other suits might [CACALA]
- Bottom story of the month: ABA president backs higher legal services budget [ABA Journal]
- After string of courtroom defeats, Teva pays to settle Nevada propofol cases [Oliver, earlier]
- Voting Rights Act has outstayed its constitutional welcome [Ilya Shapiro/Cato] More: Stuart Taylor, Jr./The Atlantic.
- Huge bust of what NY authorities say was $279 million crash-fraud ring NY Post, NYLJ, Business Insider, Turkewitz (go after dishonest docs on both sides)]
February 29 roundup
- Jackpot justice and New Jersey pharmacies (with both a Whitney Houston and a Ted Frank angle) [Fox, PoL, our Jan. 3 post]
- New Mexico: “Trial lawyers object to spaceport limits” [Las Cruces Bulletin]
- Dodd-Frank: too big not to fail [The Economist] Robert Teitelman (The Deal) on new Stephen Bainbridge book Corporate Governance After the Financial Crisis [HuffPo] Securities suits: “trial lawyers probably won’t be able to defend a defective system forever” [WSJ Dealpolitik]
- Uh-oh: U.K. Labour opposition looks at unleashing U.S.-style class actions [Guardian] “U.K. Moves ‘No Win, No Fee’ Litigation Reforms to 2013” [Suzi Ring, Legal Week]
- More on controls on cold medicines as anti-meth measure [Radley Balko, Megan McArdle, Xeni Jardin, earlier here, here, here]
- Recognizable at a distance: “In Germany, a Limp Domestic Economy Stifled by Regulation” [NY Times]
- Fewer lawyers in Congress these days [WSJ Law Blog]